The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States

被引:0
作者
Chirikova, Ekaterina [1 ]
Dorismond, Vanessa [2 ]
Cortella, Alyssa M. [1 ]
Derouen, Mindy C. [1 ]
Sawaya, George F. [1 ,2 ,3 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St,Mission Hall,2nd Floor, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
HPV vaccination; cervical cancer screening; Pap smear; age at vaccination; survey data; public health; HUMAN-PAPILLOMAVIRUS VACCINATION; ADOLESCENTS; PARENTS;
D O I
10.1177/09691413251315879
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective A better understanding of factors associated with cervical cancer screening can inform strategies for cervical cancer prevention. This study examined the relationship between age at human papillomavirus (HPV) vaccination and participation in cervical cancer screening among a nationally representative sample of women in the United States.Methods We utilized data from the National Survey of Family Growth for the years 2015-2019 focusing on women aged 18-24 vaccinated against HPV. Age at first HPV immunization was analyzed as both a dichotomous (vaccinated at 9-12 vs. 13-23 years) and a continuous variable. The outcome measured was ever having a Pap smear. Multivariable logistic regression that accounted for complex survey design was employed to estimate adjusted prevalence ratios and differences from average marginal predictions.Results The study comprised 981 individuals, representing 6.05 million women. Over half of the study population had a Pap test (57.4%). Women vaccinated at ages 9-12 were less likely to participate in screening compared to those vaccinated at ages 13-23 [risk difference: -9.1, 95% confidence interval (CI) -16.7 to -1.5)] which translates into 120,260 fewer women nationwide getting cervical cancer screening. Each 1-year increase in age at first vaccination was associated with a 1.1% (95% CI, -0.1 to 2.4%) higher probability of having a Pap test, but this linear trend was not statistically significant.Conclusions Our study underscores the importance of promoting cervical cancer screening not only among unvaccinated women but also among those who received the HPV vaccine at the recommended ages of 9-12.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
    Gao, Meng
    Hu, Shangying
    Zhao, Xuelian
    You, Tingting
    Jit, Mark
    Liu, Yang
    Qiao, Youlin
    Zhao, Fanghui
    Wang, Chen
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 36
  • [42] Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age
    Harper, Diane M.
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : S11 - S17
  • [43] Our Daughters-Ourselves: Evaluating the Impact of Paired Cervical Cancer Screening of Mothers with HPV Vaccination for Daughters to Improve HPV Vaccine Coverage in Bamako, Mali
    Crippin, Tiffani
    Tounkara, Karamoko
    Munir, Hayley
    Squibb, Eliza
    Piotrowski, Caroline
    Koita, Ousmane A.
    Teguete, Ibrahima
    De Groot, Anne S.
    VACCINES, 2024, 12 (09)
  • [44] Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study
    Fu, Yunfeng
    Li, Ying
    Li, Xiao
    Wang, Xinyu
    Lu, Weiguo
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [45] Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort
    Li, Zhi-Fang
    Jia, Xin-Hua
    Feng, Xiangxian
    Zhang, Shaokai
    Zhang, Xun
    Pan, Qin-Jing
    Zou, Xun-Wen
    Hao, Yue-Qing
    Sun, Xi-Bin
    Qiao, You-Lin
    BMJ OPEN, 2022, 12 (10):
  • [46] Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China
    Huang, Yating
    Zhang, Dantao
    Yin, Lihua
    Zhao, Jianguo
    Li, Zhifeng
    Lu, Jing
    Zhang, Xiaoming
    Wu, Chenggang
    Wu, Wei
    CHILDREN-BASEL, 2024, 11 (01):
  • [47] Impact of screening on cervical cancer incidence: A population-based case-control study in the United States
    Landy, Rebecca
    Sasieni, Peter D.
    Mathews, Christopher
    Wiggins, Charles L.
    Robertson, Michael
    McDonald, Yolanda J.
    Goldberg, Daniel W.
    Scarinci, Isabel C.
    Cuzick, Jack
    Wheeler, Cosette M.
    Joste, Nancy E.
    Kinney, Walter
    McDonald, Ruth M.
    Waxman, Alan
    Jenison, Steven
    Gage, Julia C.
    Castle, Philip E.
    Benard, Vicki
    Saslow, Debbie
    Kim, Jane J.
    Stoler, Mark H.
    Pressley, Giovanna Rossi
    English, Kevin
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (03) : 887 - 896
  • [48] Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
    Brisson, Marc
    Kim, Jane J.
    Canfell, Karen
    Drolet, Melanie
    Gingras, Guillaume
    Burger, Emily A.
    Martin, Dave
    Simms, Kate T.
    Benard, Elodie
    Boily, Marie-Claude
    Sy, Stephen
    Regan, Catherine
    Keane, Adam
    Caruana, Michael
    Nguyen, Diep T. N.
    Smith, Megan A.
    Laprise, Jean-Francois
    Jit, Mark
    Alary, Michel
    Bray, Freddie
    Fidarova, Elena
    Elsheikh, Fayad
    Bloem, Paul J. N.
    Broutet, Nathalie
    Hutubessy, Raymond
    LANCET, 2020, 395 (10224) : 575 - 590
  • [49] Improving cervical cancer screening participation by introducing HPV vaginal self-sampling to women living with HIV in Denmark- a pilot study
    Svensgaard, Siri Nana Halling
    Tranberg, Mette
    Andersen, Berit
    Petersen, Lone Kjeld
    Storgaard, Merete
    Jespersen, Sanne
    BMC WOMENS HEALTH, 2025, 25 (01)
  • [50] A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?
    Kakubari, Reisa
    Egawa-Takata, Tomomi
    Ueda, Yutaka
    Tanaka, Yusuke
    Yagi, Asami
    Morimoto, Akiko
    Terai, Yoshito
    Ohmichi, Masahide
    Ichimura, Tomoyuki
    Sumi, Toshiyuki
    Murata, Hiromi
    Okada, Hidetaka
    Nakai, Hidekatsu
    Matsumura, Noriomi
    Yoshino, Kiyoshi
    Kimura, Tadashi
    Saito, Junko
    Kudo, Risa
    Sekine, Masayuki
    Enomoto, Takayuki
    Horikoshi, Yorihiko
    Takagi, Tetsu
    Shimura, Kentaro
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (02) : 434 - 442